Detection of Radiolabeled Inflammatory Cell Macrophage Subpopulations in Chronic Respiratory Diseases: Results from

Abjal Pasha Shaik1, Asma Sultana Shaik2, Manal Abudawood1,3

  • 1Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia.

Insights

Radionuclide-labeled macrophages show promise for imaging chronic respiratory diseases. This study found 18F-FDG and 99mTc-HMPAO effectively labeled macrophages, with higher lung uptake in inflammatory models, suggesting potential for advanced nuclear imaging.

Area of Science:

  • Immunology and Nuclear Medicine
  • Investigating immune cell behavior in respiratory disease models using radiolabeling techniques.

Background:

  • Chronic respiratory diseases (CRDs) like asthma and COPD are leading global causes of illness and death.
  • Alveolar macrophages (AMs) are key immune cells with diverse polarization states (M1, M2) crucial in inflammatory processes.

Purpose of the Study:

  • To evaluate the biocompatibility and biodistribution of differently polarized mouse bone marrow-derived macrophages (BMDM) labeled with various radionuclides.
  • To assess the potential of radionuclide-labeled macrophages for non-invasive imaging in CRD-related inflammation.

Main Methods:

  • Mouse bone marrow-derived macrophages (M1 and M2 phenotypes) were radiolabeled with 99mTc-HMPAO, 18F-FDG, or 67Ga-citrate.
  • Biocompatibility and in vivo biodistribution were assessed after intravenous injection in control and inflammatory animal models.
  • Radioactivity was measured using a Packard Cobra Quantum 5002 Gamma Counter.

Main Results:

  • Both M1 and M2 macrophages exhibited higher uptake of 18F-FDG and 99mTc-HMPAO compared to 67Ga-citrate.
  • M2 macrophages showed greater radionuclide uptake than M1 macrophages; labeling did not compromise macrophage biocompatibility.
  • 18F-FDG-labeled M1 and M2 macrophages demonstrated significantly higher lung accumulation in inflammatory models versus controls at 2 hours post-injection.

Conclusions:

  • Radionuclide labeling of BMDM with 18F-FDG or 99mTc-HMPAO is biocompatible and does not alter biodistribution.
  • The findings suggest that radiolabeled macrophages could enhance detection sensitivity in nuclear imaging techniques like PET and SPECT.
  • Further research is warranted to validate non-invasive imaging of radiolabeled BMDM for understanding their role in CRD inflammation.

Related Concept Videos